1. GBp

    4,047

    Today's change

    55.50 / +1.39%

    1 year change

    -10.17%

    As of Feb 12 2016 17:14 GMT. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. February 7, 2016

    AstraZeneca cancer drug presents breakthrough

    Early trials of an AstraZeneca cancer drug have indicated the potential for “combination therapies” to widen the range...

  2. February 4, 2016

    Numbers games and existential angst

    Two down-at-heel figures loitered in a desolate landscape. It could have been Waiting for Godot, a play by Irish...

Special Reports

  1. FT Health: Devices and Diagnostics

    Digital technology is unleashing a wave of medical devices to aid in the rapid detecti...
  2. Disruption & Technology

    Just as digital technology has disrupted business, Jeremy Corbyn and his far-left supp...
Search more Special Reports on this topic.

  1. February 4, 2016

    AstraZeneca warns of lower earnings ahead of patent losses

    AstraZeneca has urged investors to keep focused on long-term growth after its shares were sent tumbling by a warning of...

  2. Fast FT

    February 4, 2016

    AstraZeneca shares hit as 2016 revenue forecast to fall

    AstraZeneca’s chief executive Pascal Soriot may be reassured that the UK drugmaker is on the right path but...

  3. Fast FT

    February 4, 2016

    Opening Quote: Shell protects divi, Compass ploughs on

    Shell’s profits have slumped with the oil price, AstraZeneca’s sales are stalling, the Bank of England is set to hold...

  4. FT Alphaville

    February 4, 2016

    FT Opening Quote

    Shell profits have slumped with the oil price, AstraZeneca sales are stalling, the Bank of England is set to hold...

  5. Fast FT

    February 4, 2016

    AstraZeneca warns of revenue, earnings drop this year

    AstraZeneca has cautioned shareholders that revenue and earnings per share this year will decline by a “low to mid...

  6. Fast FT

    February 3, 2016

    Opening Quote: Hargreaves shrugs off difficult markets

    Hargreaves Lansdown’s assets under management have risen to a record despite difficult markets for investors,...

  7. FT Alphaville

    February 3, 2016

    FT Opening Quote

    Hargreaves Lansdown’s assets under management have risen to a record despite difficult markets for investors, ChemChina...

  8. Fast FT

    February 1, 2016

    Opening Quote: Smith & Nephew, BT, EU/sardines

    Smith & Nephew says its CEO has a “highly treatable” form of cancer, BT is reshaping itself following its EE...

  9. January 31, 2016

    Gilead risks becoming victim of its own success

    During the past two years, Gilead, a California-based drugmaker, has emerged as the undisputed leader of the four large...

  10. Fast FT

    January 28, 2016

    Opening Quote: Babcock's CEO retires

    Diageo is upbeat, despite a writedown for its Brazilian liquor business, Babcock’s CEO is retiring, Jimmy Choo shoe...

  11. January 25, 2016

    Global pharma groups reveal tie-up with universities

    Three of the world’s biggest pharmaceuticals groups have teamed up with a trio of Britain’s top universities to create...

  12. January 21, 2016

    Pascal Soriot confident of AstraZeneca’s independent course

    AstraZeneca would not have made as much progress in developing new cancer drugs had it been taken over by Pfizer,...

  13. January 21, 2016

    Pascal Soriot on his rise to become CEO of AstraZeneca

    Pascal Soriot does not look like a bare-knuckle fighter. Aged 56 with a trim frame and well-groomed crown of dark hair,...

  14. January 21, 2016

    Drugmakers call for collective action on superbugs

    Most of the world’s biggest pharmaceuticals groups have backed a declaration committing the industry to help tackle...

  15. January 3, 2016

    GSK and AstraZeneca prescribe different treatments

    For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical...

  16. December 17, 2015

    BoE’s Carney plays the game of two halves

    Many Britons will be surprised to learn Mark Carney could stay on as the governor of the Bank of England. They never...

  17. December 17, 2015

    AstraZeneca adds 55% Acerta Pharma stake to swath of deals

    AstraZeneca has agreed to buy a majority stake in Acerta Pharma with an option to take full control for up to $7bn,...

  18. Fast FT

    December 17, 2015

    Opening Quote - Peppa in pink with Spielberg deal

    Peppa Pig owner Entertainment One has made a deal with ET’s Steven Spielberg, AstraZeneca has revealed it will pay $4bn...

  19. FT Alphaville

    December 17, 2015

    FT Opening Quote - Peppa in pink with Spielberg deal

    Peppa Pig owner Entertainment One has made a deal with ET’s Steven Spielberg, AstraZeneca has revealed it will pay $4bn...

  20. December 16, 2015

    AstraZeneca buys Takeda’s respiratory business

    AstraZeneca has taken another step to refill its depleted product pipeline by agreeing to pay $575m for the respiratory...

  21. Fast FT

    December 16, 2015

    AstraZeneca bolsters respiratory business with $575m acquisition

    The M&A machine in the pharmaceuticals industry is showing no signs of slowing down. UK drugmaker AstraZeneca has...

  22. December 16, 2015

    AstraZeneca pours millions into China R&D

    AstraZeneca is to invest hundreds of millions of dollars expanding its capacity to develop and manufacture drugs in...

  23. December 15, 2015

    AstraZeneca on fast track to companion diagnostics

    The green light given by US regulators last month to AstraZeneca for a new lung cancer treatment marked one of the...

  24. December 14, 2015

    AstraZeneca: in search of a blockbuster

    Jimmy Carter can tell you why AstraZeneca is contemplating paying $5bn for an unquoted Dutch biotech company with a...

  25. December 14, 2015

    AstraZeneca weighing up Acerta bid to secure blood cancer drug

    AstraZeneca is weighing a direct challenge against AbbVie and Johnson & Johnson with a potential bid for a Dutch...

  26. Fast FT

    December 14, 2015

    AstraZeneca 'exploring strategic options' with Dutch biotech

    Thought the M&A merry-go-round in the pharmaceuticals sector was over? Think again. UK drugmaker AstraZeneca says it is...

  27. December 11, 2015

    AstraZeneca achieves partial victory over NHS drug cost watchdog

    AstraZeneca, the UK pharmaceuticals group, has won a partial victory in its wrangle with the NHS drug cost watchdog...

  28. December 11, 2015

    AstraZeneca and Wallenbergs join in biological drugs venture

    AstraZeneca has teamed up with the Swedish government and the Wallenberg family to invest $100m in a new research...

  29. December 6, 2015

    Excitement rises over gene editing tool, but ethical doubts remain

    The era of genetic engineering began in 1973 when scientists in California developed “recombinant DNA” techniques that...

  30. December 3, 2015

    Pfizer to cut 120 jobs with closure of Cambridge R&D centre

    Pfizer is planning to close a research and development facility in Cambridge with the loss of up to 120 jobs, weakening...

  31. November 26, 2015

    Unhealthy drugs: Pharma struggles with its reputation

    An industry dedicated to saving and extending lives might be expected to find empathy easy. Instead, some of the...

  32. November 23, 2015

    AstraZeneca sells US rights for gastro drug to Perrigo for $380m

    AstraZeneca has agreed a $380m deal to sell the US rights for its gastrointestinal drug Entocort to Perrigo, as the UK...

  33. November 22, 2015

    Pfizer-Allergan tie-up would mark M&A high point

    Pfizer’s imminent $150bn takeover of Allergan to create the world’s biggest drugmaker will mark a fresh pinnacle in an...

  34. November 20, 2015

    Sanofi-AstraZeneca chemicals swap takes open route to R&D

    Two of Europe’s biggest drugmakers have agreed to swap more than 400,000 chemical compounds for medical research in a...

  35. November 16, 2015

    AstraZeneca gains from rival’s trial setback

    A setback for a competitor’s cancer drug helped put AstraZeneca among Monday’s biggest gainers. Clovis Oncology of the...

  36. November 15, 2015

    AstraZeneca urges antibiotics investment shake-up

    AstraZeneca has urged the government to develop a new model for incentivising investment in antibiotics and warned of...

  37. November 10, 2015

    S&P cuts AstraZeneca’s credit rating

    AstraZeneca’s credit rating has been cut by Standard & Poor's in a sign of the increased financial strain facing the UK...

  38. November 8, 2015

    Sanofi chief positive on new drugs as he warns on profits

    When Olivier Brandicourt took over as chief executive of Sanofi in April, there was a lot for him to be optimistic...

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the drugmaker's discussions with Acerta Pharma...
    December 14, 2015

    Lex on the drugmaker's discussions with Acerta Pharma

  2. Lex on the pharma group’s drug pipeline...
    September 4, 2015

    Lex on the pharma group’s drug pipeline

  3. British pharma group accuses UK of stymieing progress...
    June 2, 2015

    British pharma group accuses UK of stymieing progress